The Law of Compounding Medications And Drugs: FDA Law Blog: NOTE TO COMMISSIONER GOTTLIEB AND CONGRESS: FDA Has Ignored Congressional Intent and Broken its Commitment to Congress to Develop NDI Policies Consistent with the FDC Act as Modified by DSHEA

Monday, October 2, 2017

FDA Law Blog: NOTE TO COMMISSIONER GOTTLIEB AND CONGRESS: FDA Has Ignored Congressional Intent and Broken its Commitment to Congress to Develop NDI Policies Consistent with the FDC Act as Modified by DSHEA

NOTE TO COMMISSIONER GOTTLIEB AND CONGRESS: FDA Has Ignored Congressional Intent and Broken its Commitment to Congress to Develop NDI Policies Consistent with the FDC Act as Modified by DSHEA

No comments:

Subscribe to: Post Comments (Atom)